文献速递其他结缔组织病

肌炎中microRNA介导的肌营养不良蛋白减少:小鼠模型与人类肌肉活检研究

Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies.
PubMed 文献 · Arthritis Rheumatol · 2020-05-31

该研究在小鼠肌炎模型和6例肌炎患者肌肉活检中,验证了DMD中升高的炎症相关和靶向肌营养不良蛋白的microRNA在肌炎中同样失调,且与NF-κB调控和肌营养不良蛋白减少相关,提示获得性肌营养不良蛋白缺乏可能参与肌炎肌无力和疾病严重度。

要点

  • 严重肌炎小鼠肌肉中炎症相关和靶向肌营养不良蛋白的miRNA升高,且NF-κB调控基因表达上调。
  • 严重肌炎小鼠和重度组织学肌炎患者肌肉中肌营养不良蛋白水平降低。
  • NF-κB调控的miRNA可能介导获得性肌营养不良蛋白缺乏,联系肌炎与DMD的肌无力机制。

核心结论

  • 肌炎中可能通过NF-κB调控的miRNA导致获得性肌营养不良蛋白缺乏,从而参与肌无力和疾病严重度。

研究设计与样本

  • 使用MHC I类转基因肌炎小鼠模型研究基因和miRNA表达及组织学特征,并在6例肌炎患者肌肉活检组织中验证。
  • 小鼠根据转基因表达、体重、组织学疾病严重度和肌力/无力分为轻度或重度肌炎。

主要发现

  • 严重肌炎小鼠肌肉显示单核细胞浸润,I型干扰素和NF-κB调控基因表达升高,包括Tlr7(增加3.8倍,P < 0.05)。
  • 严重肌炎小鼠炎症相关miRNA(miR-146a、miR-142-3p、miR-142-5p、miR-455-3p和miR-455-5p;增加约3-40倍,P < 0.05)和靶向肌营养不良蛋白的miRNA(miR-146a、miR-146b、miR-31和miR-223;增加约3-38倍,P < 0.05)表达升高。
  • ChIP-seq数据的生物信息学分析显示这些miRNA的启动子/增强子区域至少有一个NF-κB共识元件。
  • 严重肌炎小鼠肌肉的Western blotting和免疫荧光分析显示肌营养不良蛋白水平降低。
  • 组织学严重肌炎患者肌肉活检中观察到NF-κB调控基因、TLR7和miRNA水平升高,肌营养不良蛋白水平降低。

临床怎么用

  • 在肌炎患者中,尤其组织学严重者,可关注肌肉miRNA和肌营养不良蛋白水平,作为潜在病理机制标志。

局限性

  • 人类验证仅基于6例肌炎患者肌肉活检组织,样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Muscle inflammation is a feature in myositis and Duchenne muscular dystrophy (DMD). Autoimmune mechanisms are thought to contribute to muscle weakness in patients with myositis. However, a lack of correlation between the extent of inflammatory cell infiltration and muscle weakness indicates that nonimmune pathologic mechanisms may play a role. The present study focused on 2 microRNA (miRNA) sets previously identified as being elevated in the muscle of patients with DMD-an "inflammatory" miRNA set that is dampened with glucocorticoids, and a "dystrophin-targeting" miRNA set that inhibits dystrophin translation-to test the hypothesis that these miRNAs are similarly dysregulated in the muscle of patients with myositis, and could contribute to muscle weakness and disease severity. METHODS: A major histocompatibility complex class I-transgenic mouse model of myositis was utilized to study gene and miRNA expression and histologic features in the muscle tissue, with the findings validated in human muscle biopsy tissue from 6 patients with myositis. Mice were classified as having mild or severe myositis based on transgene expression, body weight, histologic disease severity, and muscle strength/weakness. RESULTS: In mice with severe myositis, muscle tissue showed mononuclear cell infiltration along with elevated expression of type I interferon and NF-κB-regulated genes, including Tlr7 (3.8-fold increase, P < 0.05). Furthermore, mice with severe myositis showed elevated expression of inflammatory miRNAs (miR-146a, miR-142-3p, miR-142-5p, miR-455-3p, and miR-455-5p; ~3-40-fold increase, P < 0.05) and dystrophin-targeting miRNAs (miR-146a, miR-146b, miR-31, and miR-223; ~3-38-fold increase, P < 0.05). Bioinformatics analyses of chromatin immunoprecipitation sequencing (ChIP-seq) data identified at least one NF-κB consensus element within the promoter/enhancer regions of these miRNAs. Western blotting and immunofluorescence analyses of the muscle tissue from mice with severe myositis demonstrated reduced levels of dystrophin. In addition, elevated levels of NF-κB-regulated genes, TLR7, and miRNAs along with reduced dystrophin levels were observed in muscle biopsy tissue from patients with histologically severe myositis. CONCLUSION: These data demonstrate that an acquired dystrophin deficiency may occur through NF-κB-regulated miRNAs in myositis, thereby suggesting a unifying theme in which muscle injury, inflammation, and weakness are perpetuated both in myositis and in DMD.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Kinder TB, Heier CR, Tully CB, et al. Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies. Arthritis Rheumatol. 2020. PMID: 32009304. doi:10.1002/art.41215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。